-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Eton Pharmaceuticals, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2021 to Q4 2022.
- Eton Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the quarter ending December 31, 2022 was $13K, a 43.5% decline year-over-year.
- Eton Pharmaceuticals, Inc. Depreciation, Depletion and Amortization for the twelve months ending December 31, 2022 was $66K, a 57.4% decline year-over-year.
- Eton Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2022 was $66K, a 57.4% decline from 2021.
- Eton Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2021 was $155K, a 55.3% decline from 2020.
- Eton Pharmaceuticals, Inc. annual Depreciation, Depletion and Amortization for 2020 was $347K, a 22.6% increase from 2019.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)